Upcoming Clinical Trial Tests New Drug Combination

The Cancer Institute of New Jersey (CINJ) announces a clinical trial to evaluate a new drug combination for breast cancer. The new drug could potentially block blood vessel growth and stop certain proteins from helping cancer cells grow.